Original Research

An assessment of trends in the Iranian pharmaceutical market following domestic production of selected medications (2007‒2017) and new considerations for health policymakers

Published in: Volume 10 / Year 2021 / Issue 1
Author(s): , , , , ,
Page: 33-43

Author byline as per print journal: Marzieh Zargaran1, PharmD, PhD Candidate; Abdol Majid Cheraghali 2,3, PharmD, PhD; Fatemeh Soleymani1,2, PharmD, MPH, PhD; Rajabali Daroudi4, BSc, MSc, PhD; Ali Akbari Sari4,… Read More »

Biosimilars – status in July 2020 in 16 countries

Published in: Volume 10 / Year 2021 / Issue 1
Page: 4-32, 41

Author byline as per print journal: Hye-Na Kang1, PhD; Robin Thorpe2, PhD; Ivana Knezevic1, PhD; Daehyun Baek3, PhD; Parichard Chirachanakul4; Hui Ming Chua5; Dina Dalili6, PhD; Freddie Foo7, MSc; Kai… Read More »

Local policies on biosimilars: are they designed to optimize use of liberated resources?

Published in: Volume 9 / Year 2020 / Issue 4
Author(s): ,
Page: 163-70

Author byline as per print journal: Arianna Bertolani, PhD; Claudio Jommi, MS Study Objectives: Different policies have been implemented to enhance uptake of biosimilars. Regarding policies focussing on the demand-side,… Read More »

Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags

Published in: Volume 9 / Year 2020 / Issue 4
Page: 155-62

Author byline as per print journal: Jolita Seckute1, PhD; Ingrid Castellanos2, PhD; Steven Bane1, PhD Study Objectives: To evaluate extended in-use stability of bevacizumab biosimilar, ABP 215, after dilution into… Read More »

Systematic analysis of injection-site pain and reactions caused by subcutaneous administration of the adalimumab biosimilar FKB327 versus the adalimumab reference product via different delivery methods

Published in: Volume 9 / Year 2020 / Issue 3
Page: 108-15, 96

Author byline as per print journal: Rieke Alten1, MD, PhD; Herbert Kellner2, MD; Malcolm Boyce3, MD; Takuma Yonemura4, MD; Takahiro Ito5, MSc; Mark C Genovese6, MD Introduction/Study objectives: FKB327 is… Read More »

Qualitative survey-based evaluation of operability and convenience for the etanercept biosimilar YLB113 in a unique injection pen in patients with rheumatoid arthritis

Published in: Volume 9 / Year 2020 / Issue 3
Page: 100-7

Author byline as per print journal: Toshihiko Hibino1, MD; Tomohiko Yoshida2, MD, PhD; Akira Sagawa3, MD, PhD; Ikuko Masuda4, MD, PhD; Takaaki Fukuda5, MD Introduction/Study objective: Needle fear is common… Read More »

Pharmaceutical pricing policy in Saudi Arabia: findings and implications

Published in: Volume 9 / Year 2020 / Issue 1
Author(s):
Page: 14-21

Introduction: Many countries have introduced policies and strategies to limit pharmaceutical expenditures. These include pharmaceutical pricing policies and related strategies to control medicine prices and to ensure appropriate and stable… Read More »

Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentrations and stress conditions

Published in: Volume 9 / Year 2020 / Issue 1
Page: 5-13

Author byline as per print journal: Shon Crampton1, BA; Alla Polozova1, PhD; Darin Asbury2, BS; Alexis Lueras2, BS; Paul Breslin1, BS; Jane Hippenmeyer3, PharmD; Jennifer Litowski1, PhD; Monica Goss2, PhD… Read More »

Pharmacy chain drives choice among manufacturers of generic drugs in the US Medicare population

Published in: Volume 8 / Year 2019 / Issue 3
Author(s): , , , , , , , , ,
Page: 98-106

Author byline as per print journal: Steven Kozlowski1, MD; Ellen Tworkoski2, MS, MPhil; Carmen Dekmezian2, MS; Yanchang Zhang2, MPH; Natasha Flowers2, BA; Alvin So3, MS; Andreas M Schick3, PhD; Michael… Read More »

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Published in: Volume 8 / Year 2019 / Issue 2
Author(s): ,
Page: 49-70

Author byline as per print journal: Brian Godman1,2,3,4, BSc, PhD; Andrew Hill5; Professor Steven Simoens6, MSc, PhD; Amanj Kurdi1,7, BSc, PhD; Jolanta Gulbinovič8, MD, PhD; Antony P Martin2,9; Angela Timoney1,10;… Read More »

Page 1 of 5 1 2 3 4 5 Next »
Go Back Print